BiotechTube

SAPHRIS + Asenapine

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Schizophrenia

Conditions

Schizophrenia, Bipolar Disorder

Trial Timeline

Jul 1, 2013 → Aug 1, 2013

NCT ID
NCT01948024

About SAPHRIS + Asenapine

SAPHRIS + Asenapine is a phase 1 stage product being developed by Sun Pharmaceutical for Schizophrenia. The current trial status is completed. This product is registered under clinical trial identifier NCT01948024. Target conditions include Schizophrenia, Bipolar Disorder.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01948024Phase 1Completed

Competing Products

20 competing products in Schizophrenia

See all competitors
ProductCompanyStageHype Score
antipsychotic dose increaseEli LillyPre-clinical
23
Olanzapine + PlaceboEli LillyPhase 3
77
Olanzapine + AripiprazoleEli LillyApproved
85
olanzapine therapyEli LillyApproved
85
olanzapine-RAIM + placeboEli LillyPhase 2
52
Clozapine + OlanzapineEli LillyApproved
85
AtomoxetineEli LillyApproved
85
Risperidone + Placebo + LY2140023Eli LillyPhase 2
52
Olanzapine + olanzapine + risperidoneEli LillyApproved
85
Zotepine + RisperidoneAstellas PharmaApproved
85
ASP4345 + Matching PlaceboAstellas PharmaPhase 1
33
ASP4345 + placebo + risperidone + quetiapine + olanzapine + ziprasidone + aripiprazole + brexpiprazole + paliperidone + lurasidoneAstellas PharmaPhase 2
52
ASP6981 + PlaceboAstellas PharmaPhase 1
33
Torrent's Quetiapine Fumarate TabletsTorrent PharmaceuticalsPhase 1
33
Olanzapine HydrochlorideEli LillyPhase 1/2
41
Rapid-Acting Intramuscular Olanzapine + PlaceboEli LillyPhase 3
77
Pomaglumetad methionilEli LillyPhase 3
77
OlanzapineEli LillyApproved
85
Intramuscular Olanzapine Depot + PlaceboEli LillyPhase 3
77
olanzapine + atomoxetine + placeboEli LillyPhase 1/2
41

Other Products from Sun Pharmaceutical

Ilumya Injectable ProductApproved
85
CequaTM (Cyclosporine 0.09%) ophthalmic solutionApproved
85
Cyclosporine + Artificial tearApproved
85
AmifostineApproved
85
Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapyApproved
85